BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Nephrol. Sep 25, 2026; 15(3): 121887
Published online Sep 25, 2026. doi: 10.5527/wjn.121887
Table 1 Comparison of baseline demographic, clinical, and laboratory features by immunofluorescence classification, median (interquartile rage)/n (%)/mean ± SD

IC-MPGN (n = 100)
C-MPGN (n = 28)
P value
Age at biopsy (years)33.5 (22-45)38 (28.3-53)0.029
Gender0.978
    Male64 (64.0)18 (64.3)
    Female36 (36.0)10 (35.7)
Blood pressure (mmHg)
    Systolic150 (135-160)145 (139.2-159)0.394
    Diastolic93.5 (80.5-100)89 (80-100)0.293
First clinical manifestation0.298
    Nephrotic syndrome34 (34)10 (35.7)
    Acute GN53 (53)16 (57.1)
    RPGN13 (13)2 (7.1)
Microscopic hematuria0.018
    < 2 (trace)8 (8)7 (25)
    2-4 (+1)17 (17)3 (10.7)
    5-10 (+2)10 (10)6 (21.4)
    ≥ 11 (+3)65 (65)12 (42.9)
Proteinuria (dipstick)0.760
    Trace 1 (1)0 (0)
    +13 (3)0 (0)
    +210 (10)2 (7.1)
    +365 (65)18 (64.3)
    +421 (21)8 (28.6)
Serum creatinine (mg/dL)2.25 (1.6-3.7)2.55 (1.6-5.3)0.537
eGFR (ml/minute/1.73 m2)62.6 (40-108)57 (20-99.8)0.208
Total serum protein (g/dL)5.37 ± 1.035.88 ± 0.990.020
Serum albumin (g/dL)2.40 ± 0.602.68 ± 0.700.036
Serum C3 levels0.084
    Low (< 0.8 g/L)65 (65)23 (82.1)
    Normal (> 0.8 g/L)35 (35)5 (17.9)
Serum C4 levels0.965
    Low (< 0.16 g/L)29 (29)8 (28.6)
    Normal (> 0.16 g/L)71 (70)20 (71.4)
24 hours urinary protein (g/day)3.1 (2-4.4)3.01 (2-4.9)0.753


Write to the Help Desk